IBDEI1JX.m

IBDEI1JX ; ; 01-FEB-2022

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,25145,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25145,1,2,0)

 ;;=2^High Intensity Bhv Counsel for STD Prev,30 min

 ;;^UTILITY(U,$J,358.3,25145,1,4,0)

 ;;=4^G0445

 ;;^UTILITY(U,$J,358.3,25146,0)

 ;;=G0459^^88^1130^41^^^^1

 ;;^UTILITY(U,$J,358.3,25146,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25146,1,2,0)

 ;;=2^Inpt TH Pharm Mgmt

 ;;^UTILITY(U,$J,358.3,25146,1,4,0)

 ;;=4^G0459

 ;;^UTILITY(U,$J,358.3,25147,0)

 ;;=G0446^^88^1130^7^^^^1

 ;;^UTILITY(U,$J,358.3,25147,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25147,1,2,0)

 ;;=2^Annual Intense Bhv Tx for Cardio Dx,15 min

 ;;^UTILITY(U,$J,358.3,25147,1,4,0)

 ;;=4^G0446

 ;;^UTILITY(U,$J,358.3,25148,0)

 ;;=G0447^^88^1130^13^^^^1

 ;;^UTILITY(U,$J,358.3,25148,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25148,1,2,0)

 ;;=2^Bhv Counsel for Obesity,15 min

 ;;^UTILITY(U,$J,358.3,25148,1,4,0)

 ;;=4^G0447

 ;;^UTILITY(U,$J,358.3,25149,0)

 ;;=G0506^^88^1130^17^^^^1

 ;;^UTILITY(U,$J,358.3,25149,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25149,1,2,0)

 ;;=2^Comp Assmt Care Plan CCM Svc

 ;;^UTILITY(U,$J,358.3,25149,1,4,0)

 ;;=4^G0506

 ;;^UTILITY(U,$J,358.3,25150,0)

 ;;=G0513^^88^1130^57^^^^1

 ;;^UTILITY(U,$J,358.3,25150,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25150,1,2,0)

 ;;=2^Prolong Prev Outpt Svc,1st 30 min

 ;;^UTILITY(U,$J,358.3,25150,1,4,0)

 ;;=4^G0513

 ;;^UTILITY(U,$J,358.3,25151,0)

 ;;=G0514^^88^1130^58^^^^1

 ;;^UTILITY(U,$J,358.3,25151,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25151,1,2,0)

 ;;=2^Prolong Prev Outpt Svc,Ea Addl 30 min

 ;;^UTILITY(U,$J,358.3,25151,1,4,0)

 ;;=4^G0514

 ;;^UTILITY(U,$J,358.3,25152,0)

 ;;=G2086^^88^1130^51^^^^1

 ;;^UTILITY(U,$J,358.3,25152,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25152,1,2,0)

 ;;=2^Outpt Based Opioid Tx,70 min

 ;;^UTILITY(U,$J,358.3,25152,1,4,0)

 ;;=4^G2086

 ;;^UTILITY(U,$J,358.3,25153,0)

 ;;=G2087^^88^1130^50^^^^1

 ;;^UTILITY(U,$J,358.3,25153,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25153,1,2,0)

 ;;=2^Outpt Based Opioid Tx,60 min

 ;;^UTILITY(U,$J,358.3,25153,1,4,0)

 ;;=4^G2087

 ;;^UTILITY(U,$J,358.3,25154,0)

 ;;=G2088^^88^1130^52^^^^1

 ;;^UTILITY(U,$J,358.3,25154,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25154,1,2,0)

 ;;=2^Outpt Based Opioid Tx,Ea Addl 30 min 

 ;;^UTILITY(U,$J,358.3,25154,1,4,0)

 ;;=4^G2088

 ;;^UTILITY(U,$J,358.3,25155,0)

 ;;=U07.1^^89^1131^1

 ;;^UTILITY(U,$J,358.3,25155,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25155,1,3,0)

 ;;=3^Confirmed COVID-19

 ;;^UTILITY(U,$J,358.3,25155,1,4,0)

 ;;=4^U07.1

 ;;^UTILITY(U,$J,358.3,25155,2)

 ;;=^5159070

 ;;^UTILITY(U,$J,358.3,25156,0)

 ;;=U09.9^^89^1131^2

 ;;^UTILITY(U,$J,358.3,25156,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25156,1,3,0)

 ;;=3^Post COVID-19 Condition,Unspec

 ;;^UTILITY(U,$J,358.3,25156,1,4,0)

 ;;=4^U09.9

 ;;^UTILITY(U,$J,358.3,25156,2)

 ;;=^5161298

 ;;^UTILITY(U,$J,358.3,25157,0)

 ;;=Z20.822^^89^1132^1

 ;;^UTILITY(U,$J,358.3,25157,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25157,1,3,0)

 ;;=3^Contact w/ & Exposure to COVID-19

 ;;^UTILITY(U,$J,358.3,25157,1,4,0)

 ;;=4^Z20.822

 ;;^UTILITY(U,$J,358.3,25157,2)

 ;;=^5160187

 ;;^UTILITY(U,$J,358.3,25158,0)

 ;;=J20.8^^89^1133^1

 ;;^UTILITY(U,$J,358.3,25158,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,25158,1,3,0)

 ;;=3^Bronchitis,Acute d/t Other Spec Organisms

 ;;^UTILITY(U,$J,358.3,25158,1,4,0)

 ;;=4^J20.8

 ;;^UTILITY(U,$J,358.3,25158,2)

 ;;=^5008194

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI1JX   3751     printed  Feb 18, 2025@23:36:31                                                                                                                                                                                                    Page 2

IBDEI1JX  ; ; 01-FEB-2022

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 +2        if 'DIFQR(358.3)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.3,25145,1,0)

 +2       ;;=^358.31IA^4^2

 +3       ;;^UTILITY(U,$J,358.3,25145,1,2,0)

 +4       ;;=2^High Intensity Bhv Counsel for STD Prev,30 min

 +5       ;;^UTILITY(U,$J,358.3,25145,1,4,0)

 +6       ;;=4^G0445

 +7       ;;^UTILITY(U,$J,358.3,25146,0)

 +8       ;;=G0459^^88^1130^41^^^^1

 +9       ;;^UTILITY(U,$J,358.3,25146,1,0)

 +10      ;;=^358.31IA^4^2

 +11      ;;^UTILITY(U,$J,358.3,25146,1,2,0)

 +12      ;;=2^Inpt TH Pharm Mgmt

 +13      ;;^UTILITY(U,$J,358.3,25146,1,4,0)

 +14      ;;=4^G0459

 +15      ;;^UTILITY(U,$J,358.3,25147,0)

 +16      ;;=G0446^^88^1130^7^^^^1

 +17      ;;^UTILITY(U,$J,358.3,25147,1,0)

 +18      ;;=^358.31IA^4^2

 +19      ;;^UTILITY(U,$J,358.3,25147,1,2,0)

 +20      ;;=2^Annual Intense Bhv Tx for Cardio Dx,15 min

 +21      ;;^UTILITY(U,$J,358.3,25147,1,4,0)

 +22      ;;=4^G0446

 +23      ;;^UTILITY(U,$J,358.3,25148,0)

 +24      ;;=G0447^^88^1130^13^^^^1

 +25      ;;^UTILITY(U,$J,358.3,25148,1,0)

 +26      ;;=^358.31IA^4^2

 +27      ;;^UTILITY(U,$J,358.3,25148,1,2,0)

 +28      ;;=2^Bhv Counsel for Obesity,15 min

 +29      ;;^UTILITY(U,$J,358.3,25148,1,4,0)

 +30      ;;=4^G0447

 +31      ;;^UTILITY(U,$J,358.3,25149,0)

 +32      ;;=G0506^^88^1130^17^^^^1

 +33      ;;^UTILITY(U,$J,358.3,25149,1,0)

 +34      ;;=^358.31IA^4^2

 +35      ;;^UTILITY(U,$J,358.3,25149,1,2,0)

 +36      ;;=2^Comp Assmt Care Plan CCM Svc

 +37      ;;^UTILITY(U,$J,358.3,25149,1,4,0)

 +38      ;;=4^G0506

 +39      ;;^UTILITY(U,$J,358.3,25150,0)

 +40      ;;=G0513^^88^1130^57^^^^1

 +41      ;;^UTILITY(U,$J,358.3,25150,1,0)

 +42      ;;=^358.31IA^4^2

 +43      ;;^UTILITY(U,$J,358.3,25150,1,2,0)

 +44      ;;=2^Prolong Prev Outpt Svc,1st 30 min

 +45      ;;^UTILITY(U,$J,358.3,25150,1,4,0)

 +46      ;;=4^G0513

 +47      ;;^UTILITY(U,$J,358.3,25151,0)

 +48      ;;=G0514^^88^1130^58^^^^1

 +49      ;;^UTILITY(U,$J,358.3,25151,1,0)

 +50      ;;=^358.31IA^4^2

 +51      ;;^UTILITY(U,$J,358.3,25151,1,2,0)

 +52      ;;=2^Prolong Prev Outpt Svc,Ea Addl 30 min

 +53      ;;^UTILITY(U,$J,358.3,25151,1,4,0)

 +54      ;;=4^G0514

 +55      ;;^UTILITY(U,$J,358.3,25152,0)

 +56      ;;=G2086^^88^1130^51^^^^1

 +57      ;;^UTILITY(U,$J,358.3,25152,1,0)

 +58      ;;=^358.31IA^4^2

 +59      ;;^UTILITY(U,$J,358.3,25152,1,2,0)

 +60      ;;=2^Outpt Based Opioid Tx,70 min

 +61      ;;^UTILITY(U,$J,358.3,25152,1,4,0)

 +62      ;;=4^G2086

 +63      ;;^UTILITY(U,$J,358.3,25153,0)

 +64      ;;=G2087^^88^1130^50^^^^1

 +65      ;;^UTILITY(U,$J,358.3,25153,1,0)

 +66      ;;=^358.31IA^4^2

 +67      ;;^UTILITY(U,$J,358.3,25153,1,2,0)

 +68      ;;=2^Outpt Based Opioid Tx,60 min

 +69      ;;^UTILITY(U,$J,358.3,25153,1,4,0)

 +70      ;;=4^G2087

 +71      ;;^UTILITY(U,$J,358.3,25154,0)

 +72      ;;=G2088^^88^1130^52^^^^1

 +73      ;;^UTILITY(U,$J,358.3,25154,1,0)

 +74      ;;=^358.31IA^4^2

 +75      ;;^UTILITY(U,$J,358.3,25154,1,2,0)

 +76      ;;=2^Outpt Based Opioid Tx,Ea Addl 30 min 

 +77      ;;^UTILITY(U,$J,358.3,25154,1,4,0)

 +78      ;;=4^G2088

 +79      ;;^UTILITY(U,$J,358.3,25155,0)

 +80      ;;=U07.1^^89^1131^1

 +81      ;;^UTILITY(U,$J,358.3,25155,1,0)

 +82      ;;=^358.31IA^4^2

 +83      ;;^UTILITY(U,$J,358.3,25155,1,3,0)

 +84      ;;=3^Confirmed COVID-19

 +85      ;;^UTILITY(U,$J,358.3,25155,1,4,0)

 +86      ;;=4^U07.1

 +87      ;;^UTILITY(U,$J,358.3,25155,2)

 +88      ;;=^5159070

 +89      ;;^UTILITY(U,$J,358.3,25156,0)

 +90      ;;=U09.9^^89^1131^2

 +91      ;;^UTILITY(U,$J,358.3,25156,1,0)

 +92      ;;=^358.31IA^4^2

 +93      ;;^UTILITY(U,$J,358.3,25156,1,3,0)

 +94      ;;=3^Post COVID-19 Condition,Unspec

 +95      ;;^UTILITY(U,$J,358.3,25156,1,4,0)

 +96      ;;=4^U09.9

 +97      ;;^UTILITY(U,$J,358.3,25156,2)

 +98      ;;=^5161298

 +99      ;;^UTILITY(U,$J,358.3,25157,0)

 +100     ;;=Z20.822^^89^1132^1

 +101     ;;^UTILITY(U,$J,358.3,25157,1,0)

 +102     ;;=^358.31IA^4^2

 +103     ;;^UTILITY(U,$J,358.3,25157,1,3,0)

 +104     ;;=3^Contact w/ & Exposure to COVID-19

 +105     ;;^UTILITY(U,$J,358.3,25157,1,4,0)

 +106     ;;=4^Z20.822

 +107     ;;^UTILITY(U,$J,358.3,25157,2)

 +108     ;;=^5160187

 +109     ;;^UTILITY(U,$J,358.3,25158,0)

 +110     ;;=J20.8^^89^1133^1

 +111     ;;^UTILITY(U,$J,358.3,25158,1,0)

 +112     ;;=^358.31IA^4^2

 +113     ;;^UTILITY(U,$J,358.3,25158,1,3,0)

 +114     ;;=3^Bronchitis,Acute d/t Other Spec Organisms

 +115     ;;^UTILITY(U,$J,358.3,25158,1,4,0)

 +116     ;;=4^J20.8

 +117     ;;^UTILITY(U,$J,358.3,25158,2)

 +118     ;;=^5008194